1. Home
  2. TRML vs FBIZ Comparison

TRML vs FBIZ Comparison

Compare TRML & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • FBIZ
  • Stock Information
  • Founded
  • TRML 2021
  • FBIZ 1909
  • Country
  • TRML United States
  • FBIZ United States
  • Employees
  • TRML N/A
  • FBIZ N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • FBIZ Major Banks
  • Sector
  • TRML Health Care
  • FBIZ Finance
  • Exchange
  • TRML Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • TRML 509.8M
  • FBIZ 450.2M
  • IPO Year
  • TRML N/A
  • FBIZ N/A
  • Fundamental
  • Price
  • TRML $14.45
  • FBIZ $47.78
  • Analyst Decision
  • TRML Strong Buy
  • FBIZ Strong Buy
  • Analyst Count
  • TRML 6
  • FBIZ 4
  • Target Price
  • TRML $45.20
  • FBIZ $58.75
  • AVG Volume (30 Days)
  • TRML 360.6K
  • FBIZ 30.6K
  • Earning Date
  • TRML 03-13-2025
  • FBIZ 04-24-2025
  • Dividend Yield
  • TRML N/A
  • FBIZ 2.44%
  • EPS Growth
  • TRML N/A
  • FBIZ 20.00
  • EPS
  • TRML N/A
  • FBIZ 5.20
  • Revenue
  • TRML N/A
  • FBIZ $144,630,000.00
  • Revenue This Year
  • TRML $363.93
  • FBIZ $17.65
  • Revenue Next Year
  • TRML N/A
  • FBIZ $9.14
  • P/E Ratio
  • TRML N/A
  • FBIZ $9.07
  • Revenue Growth
  • TRML N/A
  • FBIZ 6.57
  • 52 Week Low
  • TRML $11.87
  • FBIZ $32.56
  • 52 Week High
  • TRML $29.79
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • TRML 41.51
  • FBIZ 44.01
  • Support Level
  • TRML $16.39
  • FBIZ $47.49
  • Resistance Level
  • TRML $17.36
  • FBIZ $50.10
  • Average True Range (ATR)
  • TRML 1.03
  • FBIZ 1.31
  • MACD
  • TRML -0.21
  • FBIZ 0.04
  • Stochastic Oscillator
  • TRML 3.46
  • FBIZ 37.63

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, focusing on delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: